We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
751
DELISTED
Tivo Inc
TIVO
| $234K | ﹤0.01% |
+10,236
| New | +$234K |
|
|
XLS
752
DELISTED
EXELIS INC COM STK
XLS
| $234K | ﹤0.01% |
+13,158
| New | +$243K |
|
|
DNR
753
DELISTED
Denbury Resources, Inc.
DNR
| $233K | ﹤0.01% |
14,181
-26,398
| -65% | -$429K |
|
|
BRCD
754
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $233K | ﹤0.01% |
21,913
-8,361
| -28% | -$80.6K |
|
|
ESV
755
DELISTED
Ensco Rowan plc
ESV
| $233K | ﹤0.01% |
1,100
+25
| +2% | +$5.23K |
|
756
VF Corp
VFC
$5.63B
| $229K | ﹤0.01% |
3,929
-3,477
| -47% | -$196K |
|
757
BorgWarner
BWA
$13.1B
| $228K | ﹤0.01% |
4,205
-50,807
| -92% | -$2.59M |
|
758
Shutterstock
SSTK
$198M
| $228K | ﹤0.01% |
+3,133
| New | +$265K |
|
|
JNY
759
DELISTED
JONES GROUP INC COM STK (PA)
JNY
| $228K | ﹤0.01% |
15,184
-6,216
| -29% | -$92.6K |
|
760
Landstar System
LSTR
$5.93B
| $223K | ﹤0.01% |
+3,761
| New | +$219K |
|
|
BAXS
761
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
| $223K | ﹤0.01% |
206,310
| – | – |
|
762
Associated Banc-Corp
ASB
$5.83B
| $222K | ﹤0.01% |
12,240
-32
| -0.3% | -$545 |
|
763
Brink's
BCO
$4.88B
| $219K | ﹤0.01% |
7,666
-9,934
| -56% | -$312K |
|
764
Cenovus Energy
CVE
$55.7B
| $219K | ﹤0.01% |
+7,538
| New | +$201K |
|
765
Globe Life
GL
$14.2B
| $219K | ﹤0.01% |
+4,161
| New | +$214K |
|
|
CZR
766
DELISTED
Caesars Entertainment Corporation
CZR
| $219K | ﹤0.01% |
+11,481
| New | +$265K |
|
767
Campbell Soup
CPB
$6.55B
| $218K | ﹤0.01% |
+4,843
| New | +$207K |
|
768
Cirrus Logic
CRUS
$6.53B
| $217K | ﹤0.01% |
10,914
-5,683
| -34% | -$108K |
|
|
PX
769
DELISTED
Praxair Inc
PX
| $216K | ﹤0.01% |
+1,647
| New | +$213K |
|
|
XL
770
DELISTED
XL Group Ltd.
XL
| $215K | ﹤0.01% |
6,850
-3,338
| -33% | -$99.6K |
|
771
Ryder
R
$9.83B
| $214K | ﹤0.01% |
2,670
-1,671
| -38% | -$124K |
|
|
COL
772
DELISTED
Rockwell Collins
COL
| $213K | ﹤0.01% |
2,666
-586
| -18% | -$46.1K |
|
773
Brunswick
BC
$5.13B
| $211K | ﹤0.01% |
4,639
-791
| -15% | -$34.8K |
|
774
Prologis
PLD
$135B
| $210K | ﹤0.01% |
5,142
-3,691
| -42% | -$145K |
|
|
SLH
775
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $210K | ﹤0.01% |
+3,306
| New | +$223K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.